Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195032 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
A Phase 4 study of Heart Transplant Infection Prevention, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07195032 is a Phase 4 study of Heart Transplant Infection Prevention that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07195032, a Phase 4 study of Heart Transplant Infection Prevention, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MMR vaccine according to product indication and labeling.
Conditions Studied
Interventions
- DRUG Commercial measles, mumps, and rubella (MMR) vaccine
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2027-09-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07195032
The ClinicalTrials.gov registry entry for NCT07195032 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant Infection Prevention appearing as the primary indexed condition, and to 1 intervention - of which Commercial measles, mumps, and rubella (MMR) vaccine is the first listed.
NCT07195032 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07195032 about?
NCT07195032 is a clinical study titled "Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients". The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MMR vaccine according ...
What is the current status of trial NCT07195032?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2025-09-11. Estimated completion is 2027-09-11.
What conditions does trial NCT07195032 study?
This clinical trial studies the following conditions: Heart Transplant Infection Prevention.
What interventions are being tested in trial NCT07195032?
The interventions under investigation include: Commercial measles, mumps, and rubella (MMR) vaccine (DRUG).
Who is sponsoring clinical trial NCT07195032?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195032 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.